RANOLAZINE ER 500 MG TABLET
For 30 tablets
Pharmacies pay
$4.95 filed
30 × $0.16493 per EA
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D paid
$23.53 filed
30 × $0.78436 per EA, Part D average
Medicare's price is not your price.
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
The spread
4.8× estimated
Medicare paid 4.8× what pharmacies pay.
Part D averages every strength and form sold under “Ranolazine ER” / “Ranolazine” into one figure, so it is not specific to this NDC.
OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)
Cost-plus estimate
$10.69 estimated
$4.95 + $0.74 (15%) + $5.00 fee per fill = $10.69
This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out
OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)
Open the interactive card Change the quantity, type what you were charged, and see every record in full.
What it is
RANOLAZINE ER 500 MG TABLET is how the CMS NADAC file names this product. The FDA NDC Directory lists it as ranolazine.
FDA gives its dosage form as “tablet, film coated, extended release” and “tablet, extended release” and its route as oral.
FDA lists 14 labelers (the companies named on the label) for its NDCs, among them Major Pharmaceuticals, Ajanta Pharma USA Inc. and Camber Pharmaceuticals, Inc.
FDA’s Established Pharmacologic Class for it is Anti-anginal.
The NADAC file of 2026-10-14 prices it under 18 NDCs (National Drug Codes); the FDA directory lists 15 of them.
NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.
What pharmacies pay
Pharmacies pay $4.95 for 30 tablets (30 × $0.16493 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.
NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.
What NADAC measures · Why 30 tablets · NADAC explanation codes
The 14 labelers
| Labeler | NDCs | Pharmacies pay per unit |
|---|---|---|
| Ajanta Pharma USA Inc. | 2 | $0.16493 per EA filed |
| American Health Packaging | 1 | $0.16493 per EA filed |
| Ascend Laboratories, LLC | 1 | $0.16493 per EA filed |
| Aurobindo Pharma Limited | 1 | $0.16493 per EA filed |
| AvPAK | 1 | $0.16493 per EA filed |
| Camber Pharmaceuticals, Inc. | 1 | $0.16493 per EA filed |
| Glenmark Pharmaceuticals Inc., USA | 1 | $0.16493 per EA filed |
| Lifestar Pharma LLC | 1 | $0.16493 per EA filed |
| Major Pharmaceuticals | 1 | $0.16493 per EA filed |
| ScieGen Pharmaceuticals, Inc | 1 | $0.16493 per EA filed |
| Viona Pharmaceuticals Inc | 1 | $0.16493 per EA filed |
| Westminster Pharmaceuticals, LLC | 1 | $0.16493 per EA filed |
| Zameer Pharmaceuticals LLC | 1 | $0.16493 per EA filed |
| i3 Pharmaceuticals, LLC | 1 | $0.16493 per EA filed |
| Not listed as a package in the FDA directory | 3 | $0.16493 per EA filed |
All 18 NDCs, with labeler and price
- 00904-7506-04 · Major Pharmaceuticals · $0.16493 per EA · eff. 2026-09-23 filed
- 27241-0125-02 · Ajanta Pharma USA Inc. · $0.16493 per EA · eff. 2026-09-23 filed
- 27241-0125-05 · Ajanta Pharma USA Inc. · $0.16493 per EA · eff. 2026-09-23 filed
- 31722-0668-60 · Camber Pharmaceuticals, Inc. · $0.16493 per EA · eff. 2026-09-23 filed
- 42385-0963-60 · not listed as a package in the FDA directory · $0.16493 per EA · eff. 2026-09-23 filed
- 50228-0423-60 · ScieGen Pharmaceuticals, Inc · $0.16493 per EA · eff. 2026-09-23 filed
- 50268-0722-11 · not listed as a package in the FDA directory · $0.16493 per EA · eff. 2026-09-23 filed
- 50268-0722-15 · AvPAK · $0.16493 per EA · eff. 2026-09-23 filed
- 59651-0009-60 · Aurobindo Pharma Limited · $0.16493 per EA · eff. 2026-09-23 filed
- 60687-0549-11 · not listed as a package in the FDA directory · $0.16493 per EA · eff. 2026-09-23 filed
- 60687-0549-21 · American Health Packaging · $0.16493 per EA · eff. 2026-09-23 filed
- 67877-0525-60 · Ascend Laboratories, LLC · $0.16493 per EA · eff. 2026-09-23 filed
- 68462-0319-60 · Glenmark Pharmaceuticals Inc., USA · $0.16493 per EA · eff. 2026-09-23 filed
- 69367-0293-60 · Westminster Pharmaceuticals, LLC · $0.16493 per EA · eff. 2026-09-23 filed
- 70756-0703-60 · Lifestar Pharma LLC · $0.16493 per EA · eff. 2026-09-23 filed
- 72319-0021-02 · i3 Pharmaceuticals, LLC · $0.16493 per EA · eff. 2026-09-23 filed
- 72578-0064-14 · Viona Pharmaceuticals Inc · $0.16493 per EA · eff. 2026-09-23 filed
- 90096-0151-60 · Zameer Pharmaceuticals LLC · $0.16493 per EA · eff. 2026-09-23 filed
Other strengths, forms and brands
1 other product in the NADAC file shares the FDA nonproprietary name ranolazine with RANOLAZINE ER 500 MG TABLET.
| Product | Pharmacies pay per unit | Medicare per unit |
|---|---|---|
| RANOLAZINE ER 1,000 MG TABLET | $0.27428 per EA filed | $0.78436 per EA filed |
| RANOLAZINE ER 500 MG TABLET this page | $0.16493 per EA filed | $0.78436 per EA filed |
Part D is one average per brand and generic name, over every strength and form.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
What Medicare paid
Medicare Part D paid $23.53 for 30 tablets, at an average of $0.78436 per EA in 2024 (2024-01-01 to 2024-12-31) for “Ranolazine ER” and “Ranolazine”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).
That average covers 1,248,783 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.
Medicare's price is not your price.
What Part D spending measures · Which Medicare figure OpenBill compares · How the spread is worked out
What to ask at the counter
None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.
- What is your cash price for 30 tablets? Is it lower than what I would pay through my insurance?
- If you have Medicare Part D: what is my plan’s copay or coinsurance for it? The Part D average on this page is not what you pay.
- These are questions about price, not medical advice. Do not change or stop a medicine without talking to your prescriber or pharmacist.
Questions
- Why is the comparison with Medicare for RANOLAZINE ER 500 MG TABLET labelled estimated?
- Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Ranolazine ER / Ranolazine: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's EA. Joined on generic name.